Since 1986, a quiet federal court has stood as a compact between society and the vaccinated — acknowledging that rare harm is possible, and that those who act for the common good deserve recourse. Yet the more than 11,000 Americans who report injuries from COVID-19 vaccines find themselves outside this arrangement, routed instead through an emergency compensation program that has approved fewer than one percent of their claims. The gap between what was asked of these individuals and what has been offered in return raises an old question in a new form: when a society calls upon its members to a
CBS News
· Jul 26, 2026
· legal
· 7 min read
High
Sourcing: Verified
Why COVID vaccines remain outside the federal injury compensation court
Over 11,000 Americans report COVID vaccine injuries with limited compensation access; only 60 claims approved under the countermeasures program as of June 2024.
◉
Health & Medicine
6621 related articles
Researchers uncover how bacteria survive antibiotics through tolerance…
News-Medical · 100% match
FDA approves first CRISPR gene-editing therapy for sickle cell disease
UPI News · 99% match
Maternal RSV vaccine cuts infant hospitalizations by 70%, real-world s…
Medical Xpress · 99% match
Hope amid tragedy: Ebola survivors offer lifeline in DRC outbreak
BBC News · 99% match
Race Against Time: Three Vaccine Candidates Target Rare Ebola Strain i…
Moneycontrol · 99% match
Related Coverage
The Guardian · Jul 27
AI-generated doctors spreading health myths gain millions of TikTok views
AI-generated doctor accounts on TikTok are spreading dangerous health misinformation to millions, including debunked can…
Deutsche Welle · Jul 27 Two killed, five wounded in shooting at Seattle food festivalA shooting at Seattle's Bite of Seattle festival near the Space Needle killed two people and wounded five others, includ…
The Guardian · Jul 27 Bird flu spreads into Australian wildlife as seven new cases detected in seabirdsSouth Australia reports seven suspected H5 bird flu cases in greater crested terns, marking potential evidence of diseas…
CBS News · Jul 27 2 killed, 5 wounded in shooting at Seattle Center food festivalTwo people were killed and five wounded in a shooting at Seattle's Bite of Seattle food festival near the Space Needle o…
Bias & Framing
⚖
CBS News presents factual overview of vaccine compensation programs with balanced acknowledgment of vaccine benefits and rare side effects, though framing emphasizes COVID vaccine exclusion from established VICP.
Bias Direction
center-left
Confidence
MED
Problem-solution framing that highlights a gap/complication in the system. Opens with vaccine success narrative (150M lives saved) before pivoting to COVID vaccine compensation difficulties, which could imply systemic unfairness or inconsistency.
little-known legal forum
more complicated
public health scare
putting the public health at risk
little more complicated
Regulatory/public health rationale for why COVID vaccines were placed under different compensation framework
Perspective from vaccine manufacturers on liability concerns
Data on approval rates and compensation amounts across both programs for direct comparison
Expert analysis on whether the emergency program is actually inadequate or functioning as intended
Voices of successfully compensated claimants under the emergency program
Geopolitical Impact
🌎
COVID-19 vaccines excluded from federal injury compensation program, creating legal and public health policy divergence with geopolitical implications for vaccine confidence and international health governance.
Escalation Risk
moderate
Confidence
MED
United States
European Union
Global vaccine-dependent nations
Developing countries reliant on US vaccine diplomacy
Shift in institutional trust and regulatory authority: US domestic legal framework fragmentation weakens federal health agency credibility internationally. Vaccine manufacturers gain asymmetric liability protection, potentially influencing future pandemic response cooperation. Undermines US soft power in global health leadership and vaccine equity narratives.
Similar to 1980s DTP vaccine litigation crisis that prompted VICP creation—demonstrates recurring tension between manufacturer liability protection and public confidence in vaccine safety systems.
Economic Lens
📈
COVID vaccine injury claims excluded from established federal compensation program, creating legal uncertainty and potential liability exposure for manufacturers and healthcare system.
Market Signal
mixed
Confidence
HIGH
Pharmaceutical/Biotechnology
Healthcare Services
Insurance
Legal Services
Public Health Administration
Consumers with vaccine injuries face higher litigation costs and longer claim resolution timelines outside the streamlined vaccine court system. Reduced compensation certainty may increase out-of-pocket healthcare expenses for affected individuals and create financial hardship for claimants.
Congress may face pressure to extend VICP coverage to COVID vaccines to reduce litigation risk for manufacturers and provide consistent injury compensation. Alternative emergency compensation programs may require restructuring to improve approval rates and claimant access. Regulatory clarity needed on liability frameworks for pandemic vaccines.